We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Synovis Life Technologies, Inc. (MM) | NASDAQ:SYNO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 28.01 | 0 | 01:00:00 |
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Synovis Life Technologies, Inc. (“Synovis” or the “Company”) (Nasdaq: SYNO) relating to the proposed acquisition by Baxter International, Inc. (“Baxter”) (NYSE: BAX).
Under the terms of the transaction, Synovis shareholders would receive $28.00 in cash for each share of Synovis common stock they own. The transaction has a total approximate value of $325 million. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Synovis for not acting in Synovis shareholders' best interests in connection with the sale process to Baxter.
If you own shares of Synovis and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com, visiting http://brodsky-smith.com/369-syno-synovis-life-technologies-inc.html, or by calling toll free 877-LEGAL-90.
1 Year Synovis Life Technologies, Inc. (MM) Chart |
1 Month Synovis Life Technologies, Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions